Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001096906-10-000470
Filing Date
2010-04-15
Accepted
2010-04-15 17:25:04
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 TETRAGENEX PHARMACEUTICALS, INC. FORM 10-K DECEMBER 31, 2009 ttrx10k20091231.htm 10-K 1074869
2 CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBA ttrx10k20091231ex31-1.htm EX-31.1 16389
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ttrx10k20091231ex31-2.htm EX-31.2 16317
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION ttrx10k20091231ex32-1.htm EX-32.1 8954
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION ttrx10k20091231ex32-2.htm EX-32.2 9045
  Complete submission text file 0001096906-10-000470.txt   1126995
Mailing Address 560 SYLVAN AVE 3RD FLOOR ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE 3RD FLOOR ENGLEWOOD CLIFFS NJ 07632 (201) 408-5335
TETRAGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0001362659 (see all company filings)

EIN.: 223781895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52292 | Film No.: 10752912
SIC: 2834 Pharmaceutical Preparations